嘉华药锐科技（北京）有限公司

嘉华药锐DeepKinase，以 “让癌症成为慢性病” 为愿景，用公司核心专利的功能蛋白质组学技术平台DoTK(Deep Omics ofTyrosine Kinase) ，从蛋白活性层面重新定义肿瘤。帮助肿瘤患者快速找到最适用的药物，提高患者的生活水平和生活质量，降低耐药带来的患者肿瘤复发情况；并致力于从靶点发现、靶点鉴定、药物重定位、生物标志物发现等方面全面助力新药研发。
DeepKinase is a biotechnology company commercializing a PCT patentedtechnology proteomics platform DoTK (Deep Omics of Tyrosine Kinase) toenable the next-generation precision medicines. Our vision is “TurningCancer into a Chronic Disease”. Since establishment, DeepKinase has been commi展开详情

嘉华药锐DeepKinase，以 “让癌症成为慢性病” 为愿景，用公司核心专利的功能蛋白质组学技术平台DoTK(Deep Omics ofTyrosine Kinase) ，从蛋白活性层面重新定义肿瘤。帮助肿瘤患者快速找到最适用的药物，提高患者的生活水平和生活质量，降低耐药带来的患者肿瘤复发情况；并致力于从靶点发现、靶点鉴定、药物重定位、生物标志物发现等方面全面助力新药研发。
DeepKinase is a biotechnology company commercializing a PCT patentedtechnology proteomics platform DoTK (Deep Omics of Tyrosine Kinase) toenable the next-generation precision medicines. Our vision is “TurningCancer into a Chronic Disease”. Since establishment, DeepKinase has beencommitted to improving the survival rate and overall quality of life forcancer patients by identifying the most effective drugs tailored to theneeds of individual patients, and committed to comprehensivelysupporting the development of new drugs in terms of Target discovery,Target identification, Understanding mechanism of action, Signalingnetwork construction, Drug relocation, Biomarker discovery and Patientstratification biomarkers etc.
收起